Skip to main content

Home

Primary menu

Research
Publications
Funding
Team
News
Contact

- Search

Home
Publications
Reply: How does bile acid-induced IRF3 phosphorylation mediate cholestatic liver and kidney injury?-More needs to be known.

Reply: How does bile acid-induced IRF3 phosphorylation mediate cholestatic liver and kidney injury?-More needs to be known.

Zhuang Y, Szabo G. Reply: How does bile acid-induced IRF3 phosphorylation mediate cholestatic liver and kidney injury?-More needs to be known.. Hepatology (Baltimore, Md.). 2024;80(1):E2-E3. PMID: 38442007

Publisher's Version

Last updated on 09/19/2024
PubMed

Recent Publications

miR-21: A therapeutic target for delaying severe liver disease and hepatocellular carcinoma in high-fat-diet-fed mice.
Efficacy and Safety of Erenumab for Nonopioid Medication Overuse Headache in Chronic Migraine: A Phase 4, Randomized, Placebo-Controlled Trial.
IRF3 regulates neuroinflammatory responses and the expression of genes associated with Alzheimer's disease.
In vivo Bruton's tyrosine kinase inhibition attenuates alcohol-associated liver disease by regulating CD84-mediated granulopoiesis.
Acute kidney injury in severe alcohol-associated hepatitis treated with anakinra plus zinc or prednisone.
A novel experimental model of MetALD in male mice recapitulates key features of severe alcohol-associated hepatitis.

Szabo Lab

Powered byOpenScholar^®Admin Login